Apixaban api?

What is apixaban (API) used for?

Apixaban is an anticoagulant (blood thinner) in the API (active pharmaceutical ingredient) form. It is used to reduce the risk of blood clots in people with certain conditions, including:
- Nonvalvular atrial fibrillation (to help prevent stroke and systemic embolism)
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Prevention of recurrent DVT/PE

Is “apixaban API” the same as the drug patients take?

Yes, “apixaban API” refers to the active ingredient used to make the finished apixaban medicines. The API itself is not a patient-facing product; manufacturers formulate it into specific tablet strengths and dosage regimens.

How is apixaban different from other blood thinners?

Apixaban is a direct oral anticoagulant (DOAC) that works by inhibiting factor Xa. Compared with older anticoagulants like warfarin, DOACs typically do not require routine INR monitoring for most patients, though clinical decisions depend on kidney function and individual risk.

What do people usually look up with apixaban API (patents/exclusivity)?

People searching for “apixaban API” often mean one of these:
- Patent status and time to generic or biosimilar-style entry (though apixaban is a small-molecule drug)
- Regulatory filings for generic apixaban tablets
- Sourcing and manufacturing of the API
- Pricing pressures as exclusivity ends

For patent and exclusivity research, DrugPatentWatch.com is a common starting point: https://www.drugpatentwatch.com/